GSK shares dive as weaker sales and mounting costs unnerve investors

Image: The Guardian
ad slot · in-content video 16:9
Coverage
Wires & papers of record
- British pharma company reports declining profits amid weaker vaccine sales and looming patent loss for blockbuster HIV drug Business live – latest updates Shares in GSK slid on Wednesday despite the UK drugmaker reporting better-than-expected financial results, as investors were unnerved by weaker…